E-DRUG: Free eCourse on using new TB medicines and regimens available now!
-------------------------------------------------------------------------------------------------
Dear Colleagues,
The USAID-funded Systems for Improved Access to Pharmaceuticals and
Services (SIAPS) Program is excited to announce the launch of the Using New
TB Medicines and Regimens eCourse - a free, self-paced course for health
professionals on new TB medicines, such as bedaquiline and delamanid, and
new regimens, such as the nine-month regimen. The course also covers
responsible use of these medicines and regimens for the treatment of
multi-drug-resistant TB (MDR-TB).
This course is intended for use by physicians, nurses, pharmacists, and all
health care workers who are currently engaged in the management of MDR-TB
patients. Workers in national TB control programs, ministries of health,
and nongovernmental organizations who are looking to introduce new TB
medicines and regimens in their countries will also greatly benefit from
this course.
The eCourse is available on Leadernet.org. The information in this course
has been developed on the basis of publicly available resources from the
World Health Organization and elsewhere. It has been taught via in-person
workshops to hundreds of health care workers in five countries. Now this
information is available to you at no cost.
The course includes eight modules with interactive case studies. You can
choose to review all the modules in this course or simply pick the ones
that are most relevant to your practice setting. Whether you are new to the
topics and want to view the entire course in sequential order, or if you a
need a refresher or want to view a specific topic or resource, you can do
so. You do not have to complete all the modules at once; you can go at your
own pace and learn in your free time as desired. A certificate will be
provided for those who complete the full course.
For more information or to register for this free course, please visit
https://leadernet.org/groups/courses/using-new-tb-medicines-and-regimens/.
Best regards,
SIAPS Program
Kelly Sawyer, MPH
Technical Advisor, TB
Systems for Improved Access to Pharmaceuticals and Services (SIAPS)
Management Sciences for Health
4301 North Fairfax Drive
Arlington, VA 22203
United States
E-mail: ksawyer@msh.org <ksawyer@as4h.org>